Symbolbild News Patent 500

We have been working alongside the startup 4D Lifetec since their foundation and are pleased to congratulate the team today. The young company, which has successfully developed a proprietary liquid biopsy assay for early cancer detection to clinical application, has announced a collaboration with VolitionRX.

The combination of the two companies' assays is expected to result in a completely novel, high-impact diagnostic model for early cancer detection based on liquid biopsy.

Read the detailed information here online or download the pdf.